JANE STREET GROUP, LLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in TCRX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$145,864

-$242,420 QoQ

Shares Held

144,421

-62.8% QoQ

Ownership

0.221%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,248,975,671 across 317 Biotechnology names. TCRX ranks #239 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,757,672	$130,524,721
2	RPRX	Royalty Pharma plc	2,400,382	$115,146,324
3	TGTX	Tg Therapeutics, Inc.	2,041,669	$67,824,242
4	VRTX	Vertex Pharmaceuticals Inc / Ma	122,946	$54,900,305
5	HALO	Halozyme Therapeutics, Inc.	831,707	$53,753,223
6	EXEL	Exelixis, Inc.	1,087,030	$46,622,715
7	JAZZ	Jazz Pharmaceuticals plc	223,615	$42,274,415
8	BNTX	BioNTech SE	336,757	$29,930,962

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$145,864	144,421	-62.8%	Shares	Defined	2026-05-12
2025-12-31	$388,284	388,284	+377.5%	Shares	Defined	2026-02-12
2025-09-30	$147,995	81,316	-61.9%	Shares	Defined	2025-11-14
2025-06-30	$309,423	213,396	+127.3%	Shares	Defined	2025-08-14
2024-09-30	$467,502	93,876	-5.2%	Shares	Defined	2024-11-15
2024-06-30	$579,360	99,036	-35.3%	Shares	Defined	2024-08-15
2024-03-31	$1,215,875	153,133	+83.1%	Shares	Defined	2024-05-16
2023-12-31	$487,516	83,622	+721.8%	Shares	Defined	2024-02-15
2022-06-30	$32,003	10,176	-10.0%	Shares	Defined	2022-08-16
2021-12-31	$50,881	11,307	—	Shares	Defined	2022-02-15
No filing history on record for this holder in this stock.